FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Mar 22, 2024
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on March 22, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f1193bda-b502-4076-a330-80bb2378ef4e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1233914
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.60(a)Provide proper equipment to meet requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 15, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 2, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1342670 - 2026-10-15
- FDA Inspection 1088733 - 2019-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.